Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

The Use of Colchicine in Respiratory Diseases

Author(s): Ori-Michael J. Benhamou, Shahar Geva, Miriam Jacobs, Jonathan Drew, Maor Waldman and Or Kalchiem-Dekel

Volume 9, Issue 5, 2013

Page: [300 - 304] Pages: 5

DOI: 10.2174/1573398X10666140526235154

Price: $65

Abstract

The nitrogen-containing compound, colchicine, has been used medicinally for millennia. It was first isolated from the plant Colchicum autumnale, by the French chemists P.S. Pelletier and J. Caventon. Today, colchicine is primarily used for the treatment of gout and auto-inflammatory diseases, such as familial Mediterranean fever (FMF), but it has been also investigated for its therapeutic utility in a number of respiratory diseases such as asthma, chonic obstructive pulmonary disease and idiopathic pulmonary fibrosis. While colchicine has shown some promise as an adjuvant to corticosteroid treatment, the benefit of the drug remains to be elucidated. The lack of serious adverse effects of oral colchicine at therapeutic levels should ease the design of more specific trials.

Keywords: Asthma, chronic obstructive pulmonary diease, colchicine, idiopathic pulmonary fibrosis.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy